Background: Improved neurological outcome with postarrest hypertensive hemodilution in an earlier study could be the result of more homogeneous cerebral perfusion and improved O 2 delivery. We explored global, regional, and local cerebral blood flow by stable xenon-enhanced computed tomography and global cerebral metabolism in our dog cardiac arrest model.
W e previously reported that after cardiac arrest of 12 minutes (no blood flow) in dogs, immediate postarrest hypertension with hemodilution improves cerebral outcome. 12 Since 1985, we have studied cerebral blood flow (CBF) with the stable xenon-enhanced computed tomography (CT) method 3 in our dog models of cardiac arrest. 4 We hypothesize that increasing perfusion pressure and decreasing blood viscosity postarrest can mitigate the cerebral hypoperfusion and thereby improve brain O 2 uptake/supply relationships and outcome. In this study, 6 we used our established dog model 2   -21   -22 to monitor for the first time the effect of postarrest hypertensive hemodilution on global, regional, and local CBF to 4 hours.* In exploratory subgroups, we also studied global cerebral oxygen uptake (CMRO 2 ) in relation to cerebral arterial O 2 delivery.
Materials and Methods This project was approved by the Animal Use Committee of the University of Pittsburgh (Pa.). We used 10 healthy, custom-bred male coon hounds from the same breeding colony, mean age 10 (range, [8] [9] [10] [11] [12] months and mean weight 21 (range, [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] kg. Control group I (n=5) also served other studies. It was compared with a reflow-promoted group (n=5) with immediate hypertension plus delayed hypervolemic hemodilution. Both groups were studied in 1988-1989 by the same team over 3 weeks in randomized sequence. Placebo control of treatment was not possible.
Anesthesia was induced with ketamine (10 mg/kg i.m.) and maintained with 50:50% N 2 O/O 2 plus 0.1-0.5% halothane by endotracheal intermittent positive-pressure ventilation, with paralysis by 0.2 mg/kg i.v. pancuronium as needed, and controlled normoxia and normocarbia. Sterile cutdowns were performed for monitoring and cardiopulmonary bypass. 21 - 22 Control of extracerebral variables prearrest and postarrest, from start of reperfusion with bypass of <5 minutes to resuscitation time at 4 hours, were the same in both groups.
We continuously monitored the electrocardiogram, heart rate, mean arterial blood pressure (MABP), central venous pressure, end-tidal CO^ and central venous (core) temperature. We intermittently monitored arterial blood gases and Hct. Ringer's solution without glucose was infused intravenously. We controlled MABP at 100±10 mmHg (mean±SD) by adjusting the halothane concentration before and by using norepinephrine or trimethaphan after cardiac arrest, central venous pressure at 5-15 mm Hg, Pac^ at ^100 mm Hg, PacOz at 30-35 mm Hg, base excess at ±7 meq/1, blood glucose concentration at 100-175 mg/dl before arrest, and central venous temperature at 37.5±0.5 c C. Cerebral (tympanic membrane) T, not monitored here because it would interfere with CT, was equal to central venous temperature in other experiments. 22 In preparation for the insult and during paralysis with pancuronium and intermittent positive-pres-
•Tne data, too extensive for publication here, are available upon request to interested investigators, by writing directly to Dr. Safar. sure ventilation, inhalation anesthesia was reduced with 100% O 2 for 1 minute, followed by room air for 4 minutes. Ventricular fibrillation was induced by external transthoracic AC electric shock. At the end of ventricular fibrillation (no blood flow) of 12.5 minutes, resuscitation was begun with intra-arterial epinephrine and cardiopulmonary bypass (resuscitation time, 0 minutes). Bypass was primed with 400 ml dextran 40 in 0.9% NaCl and Ringer's solution, 50:50. After 2 minutes of bypass at 100 ml/kg/min, external countershocks were started and repeated until defibrillation and restoration of spontaneous heartbeat. All dogs were weaned from bypass before 5 minutes. Intermittent positive-pressure ventilation and control of physiological variables (above) were continued to 4 hours. Cardiopulmonary bypass did not produce motion artifacts for CBF determinations, 5 as did external cardiopulmonary resuscitation. 4 After arrest, intermittent positive-pressure ventilation was continued until resuscitation time 4 hours, with Pacc^ controlled at 30-35 mm Hg, PaOj at > 100 mm Hg, central venous temperature at 37.5±0.5°C, and Hct as prescribed below.
In control group I, cardiopulmonary bypass during ventricular fibrillation was to generate a MABP of 100 mm Hg by the initial epinephrine dose of 0.0125 mg/kg i.a., and additional doses if necessary. In group II, cardiopulmonary bypass was to generate a MABP of 140 mm Hg by an initial epinephrine dose of 0.025 mg/kg i.a., and additional doses if necessary. Immediately after restoration of spontaneous heartbeat, transient MABP peaks were expected to vary between dogs in both groups, some to exceed the above levels. Mean arterial blood pressure was then to be controlled with a titrated intravenous infusion of norepinephrine: in group I at 100 mm Hg throughout, and in group II at 140 mm Hg for the first hour, 130 for the second, 120 for the third, and 110 for the fourth hour.
In both groups, the bypass priming volume induced slight hemodilution (to Hct approximately 30%) for the first 5 minutes of reperfusion. In group I at resuscitation time 5 minutes, the bypass blood (about 15 ml/kg) was returned intravenously, and Hct was restored to above 35%. In group II, the bypass blood was not returned, and additional hypervolemic hemodilution was performed by bleeding arterially 35 ml/kg and simultaneously infusing 50 ml/kg i.v. dextran 40 in 0.9% NaCl. This resulted in a Hct of about 20-25% until resuscitation time 2 hours, when the shed blood was reinfused.
Cerebral blood flow was determined with the novel noninvasive stable xenon-enhanced CT method, 3 adapted to cardiac arrest experiments with dogs. . The CBF values of all voxels in each slice and in each selected anatomic region (100-800 mm 3 volume for each region) were averaged to determine global and regional CBF, respectively. We calculated local CBF as the percentage of voxels of each CT slice (percentage area) having specific flow ranges 5 : no flow, 0-5 ml/100 cm 3 /min; trickle flow, 6-10 ml/100 cmVmin; low flow, 11-20 ml/100 cm 3 /min; normal flow for white matter, 21-40 ml/100 cm 3 /min; normal flow for gray matter, 41-120 ml/100 cmVmin; and hyperemic flow, >120 ml/100 cm3/min. We arbitrarily considered gray matter with a local CBF of <20 ml/100 cm3/min as having "inadequate CBF."
Because it interferes with xenon monitoring, N 2 O was replaced by N 2 and the analgesic effect was replaced by fentanyl given as a continuous intravenous infusion of 10 /ig/kg/hr, starting 1-2 hours before baseline CBF. About 10 minutes before starting xenon washin of the baseline CBF, halothane (<0.5%) was discontinued. No halothane was given during CBF measurements before cardiac arrest, and none at all after cardiac arrest. The inhaled gas delivered contained 67% 02/33% N 2 , which was switched to 33% Xe/67% O 2 during CBF measurements. Two baseline CBF studies were performed before cardiac arrest. Additional CBF studies were performed at 10 and 30 minutes and 1, 2, 3, and 4 hours after reperfusion. Before each CBF measurement, MABP, PaO2, Paco2, arterial pH, base excess, Hct, and central venous temperature were controlled.
Two sham experiments without cardiac arrest reported in another article 5 revealed stable reproducible global, regional, and local CBF values over time, autoregulation, and responsivity of CBF to lowered
The CMRO 2 was determined in three dogs of each group. Through a sterile 2-cm craniotomy, a PE 50 nonocclusive catheter was inserted into the sagittal sinus with the catheter tip placed 1 cm rostral to the confluence of the sinuses. For each CMRO 2 determination, the catheter deadspace was cleared and arterial and sagittal sinus blood samples were drawn at a constant slow rate into heparinized syringes, cooled, and analyzed within 2 hours for O 2 content, using a Co-oximeter. Samples for arterial and sagittal sinus O 2 contents (Cac^ and Cssc^, respectively) were taken just before each xenon inhalation without halothane. Global CMRO 2 was calculated as the global CBF of the posterior CT slice times the CaOj content gradient (i.e., global f were considered valid. Data were analyzed for group differences within times and group interaction over time using a univariate repeated-measures analysis of variance. Scheffe's post hoc procedure was used for analyzing changes within each group over time (baseline versus postarrest). The CMRO 2 data were not statistically analyzed because of small numbers. Results are reported as mean±SD.
Results
All 10 dogs followed protocol to 4 hours postarrest. Before cardiac arrest there was no statistically significant difference between groups in central venous temperature, arterial pH, PacOz, PaOz, Hct, MABP, and central venous pressure. At 10 minutes postarrest, hemodilution fluid at room temperature in group II caused mean central venous temperature to decrease from 37.5°C (baseline) to 36.2°C. Spontaneous normotension was restored within a mean of 2 minutes and 37 seconds in group I, and a mean of 1 minute and 50 seconds in group II (NS). In group I, mild hemodilution from Hct 42±3% at baseline to 30±8% at 10 minutes postarrest, caused by cardiopulmonary bypass, was transient; Hct was 34 ±4% at 2 hours and 39 ±4% at 4 hours. In group II, Hct was reduced according to protocol from 45 ±3% at baseline to 22±1% at 10 minutes postarrest; Hct was 19±2% at 30 minutes, 17±1% at 1 hour and 22±2% at 4 hours (p<0.01).
The hypertensive bout, immediately after restoration of spontaneous heartbeat, varied in both groups. According to protocol, it was higher in group II (182+42 mmHg; range, 120-250) than group I (112±24 mmHg; range, 90-200) (/?<0.01). At 30 minutes postarrest, MABP was 158 ±9 mm Hg in group II versus 110±12 in group I (p<0.01); thereafter, the difference was only numerical (NS). Central venous pressure was 3±1 mmHg prearrest in group I and 3±3 in group II; central venous pressure was 14 ±2 mm Hg at 10 minutes postarrest in group I versus 13±7 in group II; and at 4 hours, central venous pressure was 5±3 mm Hg in group I versus 8±4 in group II (NS).
In each dog, the two baseline global CBF measurements were similar (approximately 50 ml/100 cm 3 / min); there was a small SD within each group, and no significant difference between groups (Table 1 and Figure 1 ). Baseline regional CBF values (Figure 2 ) also were similar in both groups. Baseline local CBF values were also the same between groups, with essentially no voxels with local CBF <10 ml/100 cnrVmin ( Figure 1 ). During the initial transient hyperemia, neither group showed evidence of sustained no reflow foci. In both groups, hyperemia was more pronounced and lasted longer in midbrain and thalamus and less in neocortex, hippocampus, and white matter. During the hypoperfusion phase at 1-4 hours postarrest (Table 1 and Figure 1 ), mean global CBF was 51-60% of baseline in group I versus 85-100% of baseline in group II (p<0.01).
In group I (Reference 7, Table 2 ), the first postarrest CBF measurement (at 3-22 minutes after restoration of heart beat) showed diffuse hyperemia with global CBF of about two times baseline (Table 1) and no voxels with CBF <20 ml/100 cnrVmin ( Figure 1A ). During the hypoperfusion phase at 1-4 hours postarrest, mean global CBF was 55% of baseline. The percentage of voxels with a local CBF of 0-10 ml/100 cnrVmin (no flow or trickle flow) was about 15%, whereas 40% of voxels had a local CBF of 0-20 ml (worse than baseline) (p<0.0l), 44% had a local CBF of 20-40 ml, and 16% had a local CBF of 40-120 ml/100 cm 3 /min. In group II, the first postarrest CBF measurement (at 8-20 minutes after restoration of heart beat) showed the same diffuse hyperemia with global CBF of about two to three times baseline (Table 1) and also with no voxels with CBF <20 ml/100 cmVmin ( Figure IB) . During the hypoperfusion phase at 1-4 hours postarrest, however, global and local CBF values were significantly higher than in group I (p<0.01) and not significantly different from group II baseline values. At 1-4 hours postarrest, mean global CBF was 92% baseline (versus 55% in group I) ( Table 1 ). The percentage of voxels with a local CBF of 0-10 ml/100 cm 3 /min was 4% (versus 15% in group I), while 15% of voxels had a local CBF of 0-20 ml (versus 40% in group I), 40% had a local CBF of 20-40 ml (similar to the 44% in group I); and 44% had a local CBF of 40-120 ml/100 cm 3 /min (versus 16% in group I). After blood was reinfused 2 hours postarrest, there was no worsening of CBF patterns, except in dog 29, which had a slight decrease in global CBF and an increase in low-flow voxels at 4 hours postarrest ( Figure IB) .
Regional CBF values for all regions studied revealed the same flow advantages for group II as did global CBF values (/xO.Ol; for hippocampus p<0.05) (Figure 2 ). All regional CBF values (except for the white matter in group I) were >20 ml/100 cm 3 /min. Throughout 1-4 hours postarrest, all regional CBF values for gray matter in both groups were >20 ml/100 cnrVmin. In group II at 1-4 hours postarrest, all CBF values of predominantly gray matter regions were significantly higher than in group I (p<0.01) and not significantly different from group II baseline values.
The CaO2 and CssO2 values (Table 2) varied considerably between animals, but followed a consistent pattern within each dog over time. During the first postarrest CBF measurement ("10 minutes postarrest"), Cac>2 decreased as a result of transient hemodilution by cardiopulmonary bypass. At 1-4 hours postarrest, with group II further hemodiluted by protocol, CaO2 in group II was about one half of that in group I. The baseline CaO2-CssO2 was 8.0±2.7 ml/dl in group I and 9.0±2.1 in group II; after transient decrease early postarrest, it increased (worsened) in group I to 12.2±2.3 at 4 hours and remained near baseline values of 7.5 ±1.3 at 4 hours in group II. The calculated O 2 utilization coefficient also increased (worsened) similarly in both groups, from 0.4 ±0.1 prearrest to 0.7 ±0.1 at 3-4 hours postarrest. Thus, in group II the higher CBF was offset by the reduced CaO2-Arterial O 2 delivery (global CBFxCao 2 ) ( Table 2 ) postarrest was approximately the same in both groups, since in the hemodiluted dogs (group II) the normalized global CBF was offset by a CaOj of 60% of that in the control dogs (group I). The CMRO 2 values (Table  2 ) prearrest in both groups combined ranged between 2.3 and 4.5 ml/100 cnrVmin. Although global CBF at 1-4 hours postarrest was about 50% of baseline values in group I and similar to baseline values in group II (Table 1) , CMRO 2 values were similar in both groups at 1-4 hours (Table 2) , recovering from very low levels immediately postarrest to near baseline values 4 hours 
Discussion
In this study of post-cardiac arrest CBF reduction to 50% baseline with standard life support to 4 hours, we achieved normalization of global, regional, and local (multifocal) CBF values postarrest with a combination of immediately postarrest hypertension plus hypervolemic hemodilution from Hct 40% to 20%. In the 5-30 minutes postarrest CBF determinations there was no sign of protracted multifocal no reflow, with or without hypertensive hemodilution. Exploratory monitoring of CMRO 2 and related variables revealed that the flow-promoting treatment studied did not result in increased arterial O 2 delivery, because hemodilution reduced CaO2 to less than 50% baseline. This offset the increase in CBF. We had found the same combination treatment in the same model to improve cerebral outcome 2 ; an early hypertensive bout seemed more responsible for the improved outcome than the hemodilution, which gave only numerical benefit. Hypertension then might have improved outcome not via protracted improvement in O 2 delivery, but perhaps by overcoming the initial no reflow phenomenon. 9 The remaining uncertainty about the beneficial effect of moderate hemodilution to Hct 20-25% after cardiac arrest might also explain why clinical hemodilution after acute stroke has not resulted in improvement of outcome, although CBF was improved. 18 In our first cardiac arrest outcome study in dogs, done in 1974 1 and using a similar model but with external cardiopulmonary resuscitation, the beneficial effect of hypertensive hemodilution plus heparinization could have been the result of a hypertensive bout, the initial intracarotic flush with plasma substitute, or both. A similar intracarotid flush occurred in both groups in this study and in our previous outcome study with the same cardiopulmonary bypass model. The rationale for inducing hypertension includes the likelihood that the initial no-reflow phenomenon 9 is in part caused by capillary compression and increased blood viscosity, 25 both of which require initial high perfusion pressure to ameliorate. Outcome benefit from an induced hypertensive bout early postarrest had experimental support not only from our studies, In patients, immediate postarrest hypotension correlated with worse cerebral outcome. 26 The effect of epinephrine-induced immediate postarrest hypertension on cerebral outcome in patients is now being investigated with our multicenter clinical cardiac arrest study (N. Abramson, P. Safar, K. Detre, unpublished observations).
The rationale for inducing hemodilution after cardiac arrest is based on the Hagen-Poiseuille equation: Blood flow is inversely proportional to blood viscosity. Blood viscosity increases in the microcirculation during stasis. 16 Hematocrit is the main factor influencing blood viscosity, particularly in the microcirculation. During initial transient hyperemia, we saw no evidence of a persistent no-reflow phenomenon with or without hypertensive hemodilution. Both hypertension and hemodilution might increase microcirculatory blood flow if hypoperfusion postarrest is caused by vasospasm, blood sludging, or cell aggregates.
1927
- 28 The possibility of vasospasm as an important factor in the protracted cerebral postarrest hypoperfusion phase is supported by improved outcome with use of calcium entry Mockers. 29 - 30 The drugs and fluids used in group II could influence CBF and CMRO 2 , 31 irrespective of MABP and Hct. These treatments, however, could not be provided clinically without drugs and fluids.
The rationale for improving cerebral arterial O 2 delivery during the postischemic hypoperfusion phase is based on our earlier observation of mismatched CBF to CMRO 2 . 10 In the present study, the baseline CMRO 2 values of 2.3-4.5 ml/100 cm V min were low normal. The low halothane concentration of 0.1-0.5% used before, but not during, prearrest CBF measurements may have slightly increased CBF; higher concentrations seem required to reduce CMRO 2 . 31 In our study, CMRO 2 returned from very low early postarrest levels to baseline levels by 3-4 hours postarrest, while CBF was still 50% baseline ( Once postarrest hypoperfusion was established, lowering Hct seemed more effective than hypertension for improving CBF. We conducted pilot experiments at 4-5 hours postarrest. When in four dogs (CT Nos. 9,13,14, and 17) we increased MABP from between 110 and 125 mm Hg to between 160 and 190 mm Hg at 4-5 hours postarrest, global CBF and percent low-flow voxels remained essentially unchanged. When in another four dogs (CT Nos. 22,25, 26, and 27), we lowered Hct from between 35% and 50% to 25% at 4-5 hours postarrest, global CBF increased from 20-27 ml/100 cm 3 /min to 34-41 ml/ 100 cm 3 /min after hemodilution, which decreased the percentage of voxels with local CBF <10 ml/100 cm3/min in these four dogs from 5% to 3%, 15% to 6%, 11% to 2%, and 22% to 4% of voxels, respectively. In other pilot experiments at 4 hours postarrest, we tested acetazolamide (dogs CT 13 and 15) or hypercarbia of PacOj 50-70 mm Hg (dogs CT 14,17, and 18); both treatments increased global and local CBF transiently. Such acidification, however, could impair chemical recovery of neurons. These observations suggest that the delayed protracted hypoperfusion is not caused by a fixed obstruction, such as edema or thrombosis, but perhaps by mediatorinduced vasospasm or transient blood cell aggregates that yield to flow-promoting manipulations.
We conclude that after prolonged cardiac arrest, the combination of immediate hypertension plus hypervolemic hemodilution from Hct 45% to 20-25% (a rather aggressive therapy), which improved outcome in previous studies, 1 -2 can normalize the otherwise reduced global, regional, and local (multifocal) CBF. This degree of hemodilution, however, does not improve the O 2 uptake/delivery ratio postarrest, because it reduces arterial O 2 content to less than 50% of baseline, which offsets the positive flow effect. Improving the O 2 uptake/delivery ratio would require individualized titration of MABP and Hct to optimize arterial-cerebrovenous O 2 content differences. Postarrest improvement of cerebral O 2 uptake/delivery ratio might be achieved by reducing Hct with an acellular O 2 carrying blood substitute, such as a stroma-free hemoglobin or fluorocarbon solution.
